Video

Which Medications Will Be Growth Drivers in the Industry in the Next Few Years?

Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.

Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.

This video was recorded at the 2015 NACDS Total Store Expo.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Monoclonal antibodies are used to treat lung cancer. They are created in a lab and designed to target specific proteins on cancer cells, stopping them from growing and dividing.
Gene therapy in lung cancer (LC) - isometric view 3d illustration
Related Content
Microscopic image of a blood sample with magnified cellular structures, showcasing red and white blood cells, platelets, and plasma under a light microscope. | Image Credit: Man888 | stock.adobe.com
September 9th 2025

Advancing Precision Immunotherapy in Triple-Negative Breast Cancer Through Plasma Proteomics

Danielle Valletti, Assistant Editor
Pharmacy Focus Oncology Edition Podcast
September 9th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Back view of doctor checking blood pressure of a patient with sphygmomanometer in bed
September 9th 2025

Full Phase 3 Results Indicate Reduced Blood Pressure With Baxdrostat in Hypertension

Luke Halpern, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 9th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
RSV Respiratory syncytial virus vaccine vial on laboratory table with scientific research background - Image credit: AiDesign | stock.adobe.com
September 9th 2025

RSV Immunization Shows Cardiorespiratory Benefits in Adults Aged 60 and Older

Kennedy Ferruggia, Assistant Editor
Neuromuscular disorders neon glow nervous system visualizing diseases like ALS myasthenia gravis being treated advanced therapies under Neurology
September 9th 2025

Cemdisiran Monotherapy Improves Activities of Daily Living in Myasthenia Gravis

Luke Halpern, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.